Increased IL-6 secretion was ultimately shown to lead to IL-6-mediated Janus activated kinase (JAK) activation in tumor cells with subsequent downstream phosphorylation and activation of the transcription factor signal transducer and activator of transcription 3 (STAT3) (164). The gene discussed is STAT3; the disease is neoplasm.